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INTRODUCTION 
          The thyroid is a highly vascular, brownish-red structure located in the neck 
anteriorly extending from fifth cervical vertebra to the first thoracic vertebra 1. 
Thyroid gland is the largest gland  which is essential to sustain normal life . 
Thyroid is a greek word meaning "shield", introduced by Thomas Wharton2.  
           Thyroid gland consists of follicles lined by cuboidal epithelium. Each 
follicle contains clear proteinaceous colloid material. The colloid consists of 
mainly thyroglobulin. Iodide plays a important role in thyroid synthesis. About 120 
µg of iodide enter thyroid gland per day.  The iodide pump or Na +/I-  (sodium 
iodide symporter) reabsorbs iodide into thyrocytes against electrical gradient. 
Iodine is immediately bound to the tyrosine in the thyroglobulin3. 
         Thyroglobulin is iodinated to form monoiodothyrosine(MIT) and 
diiodothyrosine (DIT). By coupling reactions, thyroxine(tetraiodothyronine) T4, 
triiodothyronine T3  and  reverse T3 are formed. Thyroid peroxidase  helps in both 
iodination and coupling reactions . 
          At  the peripheral tissues,  triiodothyronine 
 
is produced from the 
deiodination of thyroxine  . T3  has shorter half life but more active than T4. 
          When the thyroid gland  become overactive and synthesize  excess of 
thyroid hormone ,it is called hyperthyroidism. The prevalence of hyperthyroidism 
has been estimated as 0.21 percent for men and 1.9 percent for women 4.  
            The most common cause of hyperthyroidism in younger age group is 
Graves' disease .   
          In graves the total daily disposal of  T 3 is disproportionately increased 
relative to that of  T 4 , indicating that the production rate of T 3  is increased . it 
could be due to increase in thyroid secretion of  Triiodothyronine
   
.Deiodinase -1  
also causes increased  peripheral conversion of  T 4   to T3  . 
 Temporary viremia of thyroid gland, certain drugs, toxic nodules can also cause 
hyperthyroidism . 
             Thyroid stimulating immunoglobulins are the antibodies that activate the 
TSH-receptor, thereby stimulating thyroid hormone synthesis and results in 
diffusely enlarged goiter . This is the etiology for graves disease. 
          In most patients thyroid gland is  massively enlarged  or of normal size in   a 
small fraction of patients.The consistency varies from soft to firm and rubbery. The 
surface may be lobular or smooth.  Continous thrills and bruits  at the upper or 
lower thyroid pole, due to increased blood flow ,which is suggestive of 
hyperthyroidism due to graves disease 5 . 
          Major  emotional  Stress and fright  before  a year or so can be a cause for 
the autoimmune activity in  Graves’ disease patients 6 .               
            It is unusually seen in men . In   females,it is more prevalent after puberty . 
The reason  for this difference being  gonadal steroids and estrogen . These 
hormones attack the B lympocyte population. But  androgens may suppress 
autoimmune activity in most of the men, so graves incidence in men is less.   
            In female patients with hyperthyroidism, pregnancy and delivery are   
precipitating events for Graves’ disease7. 
             In patients with graves disease , the thyroid gland is  characterised by a 
non homogenous infilteration  with an absence of follicular destruction. The degree 
of infilteration can be reduced by proper antithyroid treatment8 . 
              Although the intrathyroidal lymphocyte population is mixed, most  are   
T- lymphocytes. B cell germinal centres are less common than in autoimmune 
thyroiditis. 
Symptoms: 
         Symptoms of Graves' disease include goiter, nervousness , bruit over the 
thyroid, problems in  conceiving ,   increased sleeping pulse rate, palpitations, dry 
and brittle hair,  oligomenorrhea  and  amennorhea,  loss of weight,  increased 
perspiration,  warm moist skin,  lid retraction , frequent bowel movements, 
thinning of hair, hand tremors, heat insensitivity and  pretibial myxedema9 . 
Tachycardia is almost always present, and tachycardia during sleep pulse rate >90 
beats per minute distinguish tachycardia of thyrotoxic origin from that of 
psychogenic causes10. 
           Graves’ opthalmopathy presents with symptoms that include dry, gritty 
ocular sensation, photophobia, double vision and pressure sensation behind the  
eye .  
         Increase in connective tissue is due to the  hydrophilic ground substance 
accumulation like  hyaluronic acid and chondritin sulphate. 
           Digital swelling, clubbing, and  sub periosteal reaction of toes and fingers 
is called Thyroid  Acropachy.  
         Dermopathy  is seen in 99% of  graves opthalmopathy  with increased 
content of   hyaluronic acid and chondritin sulphate  and lympokine activated 
fibroblasts.                                                  
        Thyroid dermopathy is most commonly manifested on the legs as pretibial 
myxedema11.  TSH receptor expression is seen in the fibroblasts and adipocytes. 
          
     Autoimmune thyroid diseases are due to antigen specificity in suppressor 
and regulatory T lymphocyte function.12  
            This disease is rare before ten years of age.  Hashimoto’s disease and 
Graves’ disease are autoimmune disorder and females are mostly affected in both. 
There are many reasons for developing Graves’ disease . Genetic predisposition or 
family history may play a leading role in thyroid disorders. Stress can be one of the 
environmental factors for thyroid autoimmunity13. 
         Thyroid storm is also called thyrotoxic crisis usually occur in association 
with graves disease . It is a sudden incident when the thyroid hormones reach toxic 
levels with fever, perspiration, tachycardia and hypertension. The clinical picture is 
severe with hypermetabolism , accompanied by congestive heart failure, 
pulmonary edema. Incidence of thyroid storm is about 10% in hospital admissions 
precipitated by trauma, surgical emergencies, infections . It is ten times more 
common in females. It has a mortality rate of 20 to 30%14. 
 
Other causes for hyperthyroidism are, 
 
Toxic Multinodular Goiter: 
   Few nodular and spherical growths  are seen in the thyroid lobes. These nodules 
cause increased synthesis of  thyroxine and triiodothyronines 15. 
     Seen in patients over 50 yrs of age. Nodules become overactive after many 
years of thyroid enlargement. 
      Somatic mutations in the TSH receptor  gene demonstrated in toxic adenomas 
in some cases of  toxic multinodular goitre  and appeared to be different from 
nodule to nodule . 
Overmedication with Thyroid Hormone: 
         Levothyroxine given for hypothyroidism due to disease, radioactive iodine, 
can cause hyperthyroidism. 
Excessive Iodine Ingestion: 
            High iodine content in cough syrup and  amiodarone , an antiarrythmic drug  
can cause hyperthyroidism in certain patients. Amidarone   reduce the effects of 
hyperthyroidism .The clinical diagnosis of amiadarone  induced hyperthyroidism is 
difficult. Iodine may destroy thyrocytes and release thyroid agglutinogens to the 
body’s  immune system . 
 Postpartum Thyroiditis:  
             Pregnancy  is a state of immunosupression due to increased steroid 
harmone  levels. when pregnancy proceeds from first to last trimester , the disease 
ameiliorates  and after delivery  the autoimmune processes  flare up and may lead 
to the  emergence of post partum thyroiditis  16. 
              Thyroid stimulating antibody declines in the third trimester of pregnancy 
but passively transferred to foetus 17. In few cases mild to moderate  postpartum 
hyperthyroidism  is seen . Hyperthyroidism lasts for 1 to 2 months followed by 
several months of hypothyroidism. Most women will recover. In few cases 
hypothyroidism needs thyroid hormone replacement. 
Subacute Thyroiditis: 
             It may follow a viral infection with painful thyroid gland. It is a self-
limited condition associated with hyperthyroidism, hypothyroidism, and finally 
euthyroidism.  Subacute thyroiditis accounts for 15-20% of thyrotoxicosis   
patients 18 . 
Silent Thyroiditis: 
           Silent thyroiditis is thyroid gland inflammation, in which the person alternates 
between hyperthyroidism and hypothyroidism. Symptoms similar to postpartum  
thyroiditis. It has both painful and painless variants and  sometimes biopsy of the 
thyroid gland reveals the histo pathological  changes of Hashimoto s  thyroiditis 32. 
Irradiation: 
   In the general population   whom were previously  exposed  to radiation, thyroid 
auto antibodies  are common. Transient clinical opthalmopathy can occur due to 
radioactive iodine. 
   
Infection: 
         Y. enterocolitica  and other  infections of the thyroid gland like congenital 
rubella  can be the etiology for hyperthyroidism and commonly associated with 
thyroid autoimmune phenomena19. 
TSH, T3 and T4 Regulation: 
            Anterior pituitary  gland produce  thyroid-stimulating hormone (TSH),  
which regulates thyroxine and tri iodothyronine synthesis from thyroid gland. TSH 
has  been shown to be secreted in a pulsatile manner in adults20. 
          TSH production itself is regulated by thyrotropin-releasing hormone (TRH), 
which is produced by the hypothalamus .  
          TSH synthesised   by anterior pituitary is regulated by negative feedback 
mechanism. The TSH receptor is  G –protein linked with seven trans membrane 
domains and employs cyclic adenosine monophosphate and phosphoinositol 
pathways for signal transduction . 
          When the  T3 T4,  levels are high , they act on anterior pituitary and rapidly 
suppress TSH production. Low levels of thyroid hormones stimulate pituitary  
TSH Secretion and increase T3 T4, synthesis from the thyroid gland. 
         On exposure to cold, hypothalamus via TRH, increase TSH secretion from 
anterior pituitary and  during warmth, reduce TSH secretion. 
            Emotional conditions like anxiety, excitement, fear arouse the sympathetic 
nervous system and decrease TSH secretion. Both temperature modulations and 
emotional effects were not observed, after the transection of  hypophysial stalk, 
since both these effects were mediated by the way of hypothalamus21. 
             TSH is essential for increasing the number of thyrocytes, proteolysis of 
thyroglobulin, iodide pumping, iodination of tyrosine and for synthetic functions of 
thyrocytes. 
            Too little iodide, or too much iodide decreases iodide trapping and also 
thyroid hormone synthesis. Sodium –iodide symporter,( NIS)  needs TSH  for its 
positioning  on plasma membrane. NIS loses its ability to transport iodide across 
the plasma membrane in the absence of TSH . 
           TSH production is decreased by growth hormone inhibiting hormone , 
rising levels of  steroids secreted from adrenal cortex . Binding of Thyroid 
stimulating hormone to its  receptor on the thyrocytes  increases cAMP levels. 
Cyclic AMP activates protein  kinase  which  phosphorylates  the cell  and causes 
the growth of thyroid glandular tissue and   increase thyroid hormone secretion 22. 
             Cardiovascular and extra cardiovascular manifestations of hyperthyroidism 
are due to hyperadrenergic state 23. 
          Thyroid hormones is vital for stimulating metabolic processes and it  
increases the demand for coenzymes and vitamins. Basal metabolic rate is 
increased  by increasing the number of mitochondria and also by increasing the 
activity of  sodium potassium ATPase  pump.  
          One consequence of this activity is to increase body heat production and 
oxygen consumption and ATP hydrolysis rate. Thus body temperature parallels 
thyroid hormone fluctuations. 
       Hyperthyroid  patients  usually  have normal urinary and  plasma epinephrine, 
norepinephrine levels and  show normal response for epinephrine infusion and 
there is no evidence for increased catecholamine  synthesis or metabolism  at nerve 
endings.       
Thyroid activity in foetus: 
           Thyroid hormone is important for fetal, as well as neonatal, brain 
development and nerve myelination . Thyroid hormone production rate per unit 
area is more in neonates and children than adults. 
          Congenital hypothyroidism occurs in babies if thyroid gland does not 
produce adequate thyroid hormones.  Mental retardation is prevented  if  the 
hypothyroid child is treated within a year of life. 
Effect of Hyperthyroidism on Cardiovascular System:  
          There is  increased circulatory demands which causes modifications in 
cardiac functions  .Cardiovascular alterations also  results from the 
hypermetabolism and there arises a  need to  release the heat produced    .                 
            Thyroid hormones acts on cardiac cells by altering the action of pacemaker   
(sino-atrial node) .It increases the myocardial oxygen utilization, coronary blood 
flow  and the systolic of  the heart. Heart has 2 myosin heavy chain isoforms, α 
MHC and β MHC encoded by two genes located on short arm of chromosome 17. 
           In hyperthyroidism circulatory T3  enter cardiac  myocytes  combines with 
its receptors and enters the nucleus, causes enhanced  transcription of α myosin 
genes- α MHC, β adrenergic receptors , G proteins, Na K ATPase and while it 
causes inhibition of  transcription of  β MHC, phospolamban, two types of 
adenylcyclase.  Thus the cardiac contractility is increased24.  
          Excessive thyroid hormone production increase the tissue utilization of 
oxygen, thereby increasing the metabolites which cause vasodilatation. Therefore 
there is increase in the blood flow, cardiac output and heart rate. Increased thyroid 
hormones, by increasing the enzymatic activity, increases the  strength of the 
heart25.                          
           In our study , sympathetic noradrenergic system alterations with altered  
thyroid functions  were studied in the subjects. Thyroid hormone variations on 
certain cellular mechanisms   in the heart causes many cardiovascular 
abnormalities.  
           It is well established hyper dynamic cardiovascular state  with low  
vascular resistance and high cardiac output exist in hyperthyroidism  .                                                                               
It  is   also associated with tachycardia,  increased cardiac muscle oxygen 
consumption , increased left ventricular diastolic and systolic function, low 
systemic vascular resistance and increased prevalence of arrhythmias,  decreased 
exercise performance, and increased risk of cardiovascular mortality.                             
Pulse pressure is increased due to decrease in diastolic pressure and increase  in 
systolic pressure . 
Heart Rate Variability as an index of Cardiac Autonomic activity:  
            Autonomic Nervous System can be assessed using HRV analysis. The 
cardiac rhythm influenced by sympathetic and parasympathetic dysfunction can be 
evaluated  by the interbeat  variations of R-R interval26.   
           The spectral variation of the heart rate in the lower (LF) and higher 
frequencies (HF) has a significant relationship to sympathetic and parasympathetic  
activity, respectively. 
            An exageration of sympathetic nerve tone in cardiac activity induces 
tachycardia and reduces cyclical beat-to-beat variations, whereas increased 
parasympathetic nerve activity reduces heart rate and increases Heart Rate 
Variability .  
              These derangements in autonomic nervous system can be found out  by 
HRV, and the HRV indices  help us to assess the disease severity in hyperthyroid 
patients. 
Effect of Autonomic  nervous system: 
                The thyroid glands are regulated  by both neural and endocrine 
hormones. Many ganglia contribute to the innervation of this gland . There are two 
divisions in the autonomic nervous system namely, sympathetic and vagal  nervous 
systems. Both are antagonistic in their target actions. Cardiac inotrophic effects are 
partly due to adrenergic stimulation.  
          The increased sensitivity of atria to beta-adrenergic agonists is due to 
increased beta-adrenoceptor density and sympathetic stimulation on the β1 
receptors in the heart causes increase in the heart rate and cardiac output of 
hyperthyroid patients . 
           Thus increased thyroid hormones increases β adrenergic receptors, and 
sympathetic activity on beta receptors which  is mainly via adenyl cyclase-cyclic 
AMP.  The  cardiovascular derangements mostly get  reversed by antithyroid 
treatment  and normal thyoid function can be restored  after some time. 
  
II. AIM AND OBJECTIVES 
PRIMARY AIM:              
     To investigate a possible relationship between hyperthyroidism and autonomic 
imbalance in hyperthyroid patients using spectral analysis of  HRV. 
SECONDARY AIM: 
•  To compare HRV of  hyperthyroid and normal volunteers. 
• To assess the cardiovascular  risk  in hyperthyroid patients using HRV. 
OBJECTIVE: 
1. To compare HRV analysis between hyperthyroid and normal volunteers. 
2. To study the type of autonomic imbalance in patients who are hyperthyroid. 
   3. To study the sympathetic influence in hyperthyroid and its role in the   
pathophysiology of cardiac complications. 
 
 III.REVIEW OF LITERATURE 
   Autonomic Nervous  System   
         The autonomic system  has  afferent nerves which carries information 
from viscera  and the central processes enter spinal cord or brainstem. 
Peripheral processes of afferents run with efferent nerves.  
            Word  ” autonomous “  is  taken  from  greek  word  the  autos,  
meaning   self and the memos , meaning control . Thus autonomic nervous 
system is  an involuntary system which controls the vegetative functions,  so it 
is also  called  vegetative system. 
                An important function of autonomic nervous system is to                                 
maintain homeostasis. i.e, constant internal environment by releasing 
epinephrine, insulin and glucagon or renin, vasopressin Sympathetic and 
parasympathetic divisions are complementary in nature rather than 
antagonistic.  
         Autonomic nervous system  has afferent neuron in dorsal root ganglia, 
connector neuron in the dorsal horn of grey matter , conducts impulse to the 
ventral horn)  and ventral horn cell  which transmits the efferent impulses to 
skeletal muscle. 
                Sympathetic division can be considered as the accelerator i.e, it    
acts during fast responses flight or fight  reactions and the parasympathetic 
division acts as the brake and functions during resting conditions                         
eg. "feed and breed" 27. 
 
        Both the divisions  of autonomic nervous system carry visceral 
afferent and sensation information like vasomotor, respiratory, and viscera 
somatic reflexes and interrelated visceral activities28 . 
 
                ANS is responsible for activities of the organs of digestion, circulation, 
excretion, respiration, reproduction as well as sweat, lacrimal, salivary glands and  
adrenal medulla29.  
 
                ANS relays between central nervous system and the visceral organs by 
the way of peripheral ganglia. Central neurons that contributes information to 
autonomic system has cell bodies located along an interrupted string of  grey 
matter in brain stem and spinal cord. Preganglionic sympathetic fibres  causes 
release of epinephrine and nor epinephrine from adrenal medulla. Preganglionic  
Parasympathetic nerves  go directly to vicinity of viscera .  
 
                            
 Cells of origin of sympathetic division of the autonomic nervous 
system are located in lateral horn spinal grey matter from eighth cervical and 1st 
thoracic through 3rd lumbar segmental levels. 
 
Autonomic Nervous System and Hypothalamus: 
              Th nerves from the  hypothalamus  projects  to the parasympathetic  
vagal  nuclei  and other neurons  in the  medulla. Medulla also has  a group of 
neurons that descend to the sympathetic system in the   spinal cord .Withall 
these connections, the hypothalamus can control rate of the heart, cardiac 
functions, and vasoconstriction, 30. 
             The suprachiasmatic nucleus  project  to  the paraventricular  nucleus      
of   hypothalamus  (PVN). The  PVN  and  arcuate nucleus  has  TRH (thyroid 
releasing hormone)  expressing neurons . 
            TRH is stored in median eminence   from where it is released in to the 
hypothalamo-hypophyseal portal vessels which reach the anterior pituitary 31. 
            TRH acts on the basophils via adenylcyclase  - cAMP  pathway  and 
causes the release of TSH  from the pituitary gland. Hypothalamus secretes 
TRH when the thyroid  hormones  secretion becomes low (negative feedback)  
and also by nervous stimuli like exposure to cold or stress 32. 
 Autonomic Nervous System and Thyroid Gland: 
                The  hypothalamo pituitary thyroid  axis and neural control                         
of the thyroid gland are the essential regulators of thyroid function .The 
autonomic nervous system derives from the neural crest which also gives 
rise to dorsal root ganglia.  
           The thyroid  receive its sympathetic innervation  mostly  via 
superior cervical ganglion (SCGs). Jugular nodose ganglia  and cervical 
dorsal root ganglia also supplies the thyroid gland . 
          Parasympathetic nerves  via branches of  superior  laryngeal nerve  
and  recurrent nerve,  also supplies the thyroid gland 
               The  thyroid  nerve ,which is a vagal branch , projects to  the  thyroid  
ganglion  which  has vasoactive  intestinal  peptide  and  neuropeptide Y  
expressing  neurons  33. 
               Autonomic innervations to the thyroid gland may interfere with T3 , 
T4 concentrations by altering the thyroid responsiveness to TSH and also by 
interfering the deiodination of Thyroxine to Triiodothyronine
 
by  the 
Deiodinase enzyme
 
  .  
                            Nuclear effects of thyroid hormone are delayed  for 1 
hour,which is the time taken for transcription and translation of specific enzymes 
or contractile proteins.  Extranuclear effects may influence plasma membrane 
transport of calcium, sugar, and amino acids in addition to directly influencing 
mitochondria and are very rapid, occurring within minutes. It is possible that 
there exists an interaction between the adrenergic system and the thyroid 
hormone system, which may also contribute to the cardiac actions of thyroid 
hormone 34.  
                Hyperthyroidism challenges the adrenal   function  by decreasing  the 
urinary excretion of 17-ketosteroids .Increased thyroid  hormone  effects are  
similar to those induced by epinephrine, including  tachycardia, increased cadiac 
output and enhanced glycogenolysis, lipogenesis, and calorigenesis. 
                The relationship between graves  opthalmopathy, hyperthyroidism and 
thyroid dermopathy was ascertained and it was showed that thyroid dermopathy 
was seen in 13% of patients  with graves opthalmopathy 35. 
             Some of the manifestations of thyrotoxicosis  like eyelid retraction, 
tremor, excessive  sweating and tachycardia are atleast partly alleviated by 
adrenergic antagonists. 
            Graves disease was first named after Robert Graves in 1835.He observed  
thyroid gland enlargement in patients along with  palpitations, exophthalmos, 
pretibial myxedema 36. Cardiovascular signs like increased heart rate, murmur, 
hyperdynamic precordium, abnormal heart sounds, ectopic beats and irregular 
rhythm were also associated. 
Heart Rate Variability:  
                     HRV has emerged as the common procedure to assess autonomic 
variations in humans for clinical studies from the last decade.                                       
Autonomic nervous system  can be evaluated by HRV is  in the form of time-
frequency representation 37. 
                 HRV is analysed from the interval between R-R waves. Many 
research articles have been published pertaining to HRV. Most commonly used 
spectral analysis method is fast fourier transformation(  FFT) 38.  
              The same is used in our study. The inputs and frequency components  
are analysed  rapidly and the computation time can be reduced using FFT. 
              HRV can also be denoted as cycle length variability, RR Variability 
and RR interval tachogram. Cardiac function is good if the variability between 
RR interval is more. Cardiac mortality increases with sympathetic dominance 
and in parasympathetic inhibition. High-frequency domain decrease under 
acute pressure and emotional states 39 .  
History of HRV: 
           HRV has a broad application in cardiology.  Fifty years back , in Russia, 
the  Science of heart rate  variability was developed in one of the space 
program 40. 
           HRV analysis is a excellent tool  to depict  the autonomic nervous 
system (ANS), because the HRV regulation is mainly from the sympathetic 
and parasympathetic nervous systems. 
           In 1965  the clinical application of HRV was first brought out by Hon and 
Lee 41 . He followed there is alterations in interbeat intervals before any 
appreciable change occurred in heart rate itself ,for example fetal distress.  
           In diabetics, the autonomic neuropathy RR interval  is usually reduced . 
this was evaluated by Ewing 42  using a number of bed side tests 
             Wolf et al 43, predicted that decreased heart rate variability is 
associated with increased risk  of post infarction mortality in cardiac patients. 
            Akselrod et al 44, developed heart rate variations analysis  to investigate 
the interbeat differences in  cardiovascular  system. 
          Since the last five decades, different spectral analysis has been applied.  
Using Tachogram RR interval can be assessed  . Power spectral density (PSD) 
analysis provides the basic information of how power (variance) distributes as 
a function of     frequency .  
              Md Rasel Kabir, Noorzahan  Begum  45, found out that  
Hyperthyroidism is associated with altered cardiac autonomic nervous activity 
(CANA). Mean R-R interval was significantly lower  but there is increased 
heart rate in untreated  thyrotoxic patients. SDNN and RMSSD were 
significantly lower in untreated hyperthyroids.  He concluded that decreased 
vagal modulation may be restored following adequate treatment. 
              V Cacciatori,  F Bellavere    et al 46, conducted  HRV analysis in  
hyperthyroid patients to study the autonomic balance . In his study, heart rate 
variability was evaluated in different conditions. The  power spectral analysis  
during standing, lying and rest  were measured by analyzing  the power spectral 
density of heart rate cyclic variations. While performing autonomic function tests, 
reflex response of heart rate during lying to standing was higher in controls than  
hyperthyroid patients.   He also performed valsava maneuver and  deep breathing 
tests,  which showed no differences in subjects. After methimazole treatment  the 
altered cardiovascular parameters were restored, with slight predominance of the 
vagal tone  in the thyrotoxic  patients. Thus concluding  that thyroid hormone 
excess may be the root cause for sympathetic dominance and sub normal  vagal 
component. 
 
                Karthik S, Pal GK, Nanda N  et al 47,  in his research, found 
autonomic imbalance in thyroid dysfunctions in various conditions like  
hyperthyroid, hypothyroid, normal females. Thyroid profile, body mass index, 
basal heart rate , blood pressure  and spectral indices of HRV (TP, LFnu, HFnu 
and LF-HF ratio, mean RR, SDNN and RMSSD) were studied in all the 
subjects. Sympatho vagal imbalance was more prominent in thyrotoxic patients.   
In all the subjects, LF-HF ratio was correlated with thyroid profile and he 
emphazised that the  Sympathovagal imbalance was detected due to both vagal 
withdrawal and sympathetic overactivity   and  stressed on , to improve vagal 
the component  in thyrotoxic  subjects to attain autonomic equilibrium and 
homeostasis in cardiovascular system. 
 
            Tobaldini E, Porta    et al 48 ,  conducted a research on heart rate 
variability ( in a short term)  with conditional entropy  indices in hyperthyroid 
and euthroid females.  The study was conducted in different positions like 
standing, and rest. In both study groups, during standing, the mean heart period 
was reduced but there is no significant difference at rest. The low frequency 
power was elevated in thyrotoxic groups than the euthyroids. During standing,  
the respiratory rate and complexity was increased in the thyrotoxic group than 
the euthyroid groups. There is a significant complexity in cardiovascular  
function, which could be attributed to both  sympathetic  over activation and 
also to the increased metabolic effects of the elevated thyroid hormone levels. 
           Thyroid h ormone stimulates the metabolic  activities and increases the 
basal rate of oxygen consumption and heat production in most tissues except 
the brain, retina, gonads, lungs, spleen. Increase in resting metabolic rate found 
in hyperthyroids is partly due to an increase in hepatic metabolism in liver 
cells. 
*
 
             Stuart Gordon  recognised   in his study that  a patient  may  suffer from 
hyperthyroidism  in the absence  of   a continually elevated metabolic rate, since 
the  disease is  characterised by remission and exacerbations, the basal metabolic 
rate can be normal or subnormal also and this occurs mainly in  patients with 
nodular goitre and the degree of degenerations are more in nodular goiter 49. 
          Early in 1928, Clute suggested that there were patients with history  , 
physical examination and investigations entirely consistent  with  
hyperthyroidism , yet the basal metabolic rate is normal or subnormal 50.  
         During  1931, plummer has placed on record  of hyperthyroid subject 
having a basal metabolic rate of  -9 but the normal basal metabolic rate can vary 
from -10 to 15. Thus proved that hyperthyroidism can occur with least possible 
basal rate51. 
                 Chen JL, Chiu HW  et al 52, showed that  autonomic  imbalance state 
prevails in hyperthyroidism .It is characterized by both increased sympathetic and 
decreased vagal modulation of heart rate which is  analysed from spectral analysis 
of heart rate variability.   HF nu,  LF nu, VLF, HF, LF ,Total power  were 
analysed in the study  groups. (LF/HF) Ratio an low frequency  is increased  in 
hyperthyroids than controls.  After antithyroid treatment, HRV parameters were 
gradually brought back to normal  levels like those of the controls. The study 
brought out relationship between HRVparameters  and the thyroid function tests. 
           Burggraaf J, Tulen JH, et al 53, suggested that there is  Sympathovagal 
imbalance in   hyperthyroidism.  In thyrotoxic cases,  HF parameters are  
decreased along with SDNN parameters. This proves  diminished resting 
parasympathetic inputs to the cardiovascular system . Raised urinary levels of 
epinephrine and norepinephrine  clearly depicts  the enhanced sympathetic 
activity in the cases.  Thus  both the craniosacral and thoraco lumbar outflow 
are deranged causing variations in heart rate. 
                    Girard A, Hugues FC et al 54, computed the  HRV analysis by studying 
the variability of blood pressure and heart rate in thyrotoxic cases. It showed a fall 
in   HF parameters.  Overall heart period variability is decreased in the cases than 
the controls in the supine position.   There is a clear deficit in the orthostatism-
induced mid-frequency systolic blood pressure rise in the hyperthyroid state  
compared with the euthyroid state. Significant decrease in vascular response to 
standing  is elicited .  
               Barczy M, Tabor S, Thor P   et al 55, studied the sympathovagal system 
with heart rate variability analysis in hyperthyroid patients . Reduction of RR 
intervals, increase of LF and HF ratio and in decrease of SDNN in 
hyperthyroidism. After attaining pharmacological euthyroidism and surgical 
euthyroidism, there were increase in RR intervals, reduction of LF/HF ratio and 
increase of SDNN in comparison to hyperthyroidism  .  
                   Jin Long Chen et al56 , suggested  that  hyperthyroid patients and 
normal controls could be distinguished by correlation dimension  of heart rate 
variability. He  found that there is reductions in the  R–R interval in cases  than 
controls .Also there is reduced correlation dimension  in hyperthyroid patients . 
This depicts the  reduced complexity and decreased  tolerance to cardiovascular 
stresses in thyrotoxic subjects. Thus this is the reason for  exercise intolerance 
and anxiety, irritability in hyperthyroid patients.  
                  Osman, F and Franklyn et al 57, assessed time-domain parameters and  
heart rate turbulence (HRT) in severe  thyrotoxicosis subjects . Measurements of 
HRT (onset and slope) decreased in patients with overt hyperthyroidism, but 
following antithyroid treatment  , the slope is restored   to normal values with 
antithyroid treatment . 
                     1991, President George Bush had tachycardia and was diagnosed 
with atrial fibrillation ,which is  usually  seen  in older individuals with high 
blood pressure, coronary artery disease, valves dysfunction. He was not known 
to have these problems, but after medical evaluation, he was found to have 
Graves’ disease. Atrial fibrillation was found in 25% of individuals who had 
developed hyperthyroidism over the age of sixty58. 
                    Massimo Casu, et al 59, analyzed the sympathetic and 
parasympathetic control of heart rate variability (HRV) in the population who 
had undergone thyroidectomy  and later  supplemented with  Levo -thyroxine 
and I131 therapy for thyroid carcinoma.  Systolic and mean Blood Pressure were 
elevated in hyperthroids. Decreased sympathetic tone with preserved vagal 
tone, was detectable in patients with hyperthyroxinemia after getting thyroxine 
treatment .Gradual restoration  of increased systolic and mean blood pressure 
but not diastolic BP. 
                      Frans Brandt  60  showed that severe hyperthyroidism was associated 
with  coagulation disorder, rhythm disturbances, hemiplegia, and vascular 
embolism . Incidence of  Cardiovascular morbidity and mortality in hyperthyroid 
patients increased to 20% . 
                       Marcus Dörr 61 studied the relationship between function of the 
thyroid gland ,Left Ventricular hypertrophy, cardiac muscle mass . Decreased 
serum thyroid hormone levels and  thyroid stimulating hormone levels predict 
cardiovascular mortality, which could be described by left ventricular 
hypertrophy (LVH).  
               Tremendous burden is imposed  on the heart in hyperthyroidism. In 
such patients, even at rest the working capacity  of the heart is so great as the 
normal heart, when undergoing the most strenuous exercise and if it is allowed 
to continue, myocardial reserve will decrease and myocardial damage will 
occur eg.  Cardiac hypertrophy. 
            Subclinical hyperthyroidism could be the cause for increased risk of atrial 
fibrillation and cardiac mortality, osteoporosis in women of postmenopausal age 
group. 
            The study by Kaminski suggests that subclinical hyperthyroidism when 
compared  to normal thyroid status may be associated with a statistically 
significant increase of QT interval dispersion.  In subclinical hyperthyroidism, 
prevalence of increased  ventricular extra systole, increased arterial blood Pressure, 
and changes in Heart rate variability like mildly elevated LF parameters are    
appreciated  62.  
                Hartong R,Wang N et al 63, suggested that thyroid hormone T3 
regulates gene transcription of the  Ca-ATPase in the  sarcoplasmic reticulum. So   
increased thyroid hormone responsiveness is pronounced . 
              Eric Oetter  64  conducted  a Heart Rate Variability Research .He 
found out whenever body is confronted with stress conditions, there  is 
decreased variation between beats. This is suggestive of  overt activity of 
sympathetic  nervous system .The “fight-or-flight” response come in to action 
to maintain homeostasis. When the body assumes resting condition, the heart 
rate variability increases, indicating  the increase in the parasympathetic tone 
of the autonomic system. 
                Atrial fibrillation,  cardiomyopathy,  sinus arrhythmia, mitral 
stenosis,  mitral valve prolapse ,  cardiac failure  are the different types of 
cardiac pathology in hyperthyroid patients  diagnosed from echocardiography, 
chest radiograph and electrocardiography. 
               Anne R. Cappola, M,  showed that thyroid dysfunction is associated 
with increased prevalence of  cardiovascular risk. The study was conducted in 
people above 65 years and TSH was tested. 82 % of the study population  
showed euthyroid status.15 %  were known  to have subclinical 
hypothyroidism .1.6%  suffered from hypothyroidism, and 1.5 % had 
subclinical hyperthyroidism .  Subjects with subclinical hyperthyroidism had 
twice the risk of developing atrial fibrillation when  compared to the people 
with normal thyroid function 65 .  
          Hyper active thyroid gland is linked with an increased risk for atrial 
fibrillation (a type of abnormal heart rhythm) . But the normal or  under active 
thyroid gland has lower risk for cardiovascular problems or death66. 
               Simply the presence of high thyroxine levels in euthyroid  patients of 
60 years or older was known to have three times  higher risk in developing  
atrial flutter or fibrillation 67. 
                 Barczyński M et al 68  estimated  sympathetic and parasympathetic 
function in hyperthyroids  by the  spectral analysis of heart rate variability and 
evaluated  the impact of pharmacological and surgical treatment on the ANS 
function. Statistical significance was found in reduction  of  range  of  RR 
intervals, in increase of LF/HF ratio and in decrease of SDNN in 
hyperthyroidism in comparison to the control group .Pharmacological therapy 
with thyreostatics  and surgical treatment can  normalizes  autonomic nervous 
system to the  control group level.  
            Thirtysix  years of follow-up of hyperthyroidism  indicate that Left 
Ventricular hypertrophy is reversible and reversal towards euthyroid status 
provides significant benefit for the anatomical manifestations of  Left 
ventricular  hypertrophy.  Incidence of left ventricular hypertrophy and 
cardiovascular morbidity  were found to be different in the cases. This is 
because , the cardiovascular health is  also assessed by glucose intolerance, 
high blood pressure, lipid profile  alcohol and smoking  69.  
                    Noh JY, Nakamura Y et al70 studied Sympathetic overactivity 
occurs in Graves' disease, but little is known about autonomic nervous 
function in their eyes They examined this function of the intraocular 
muscles in 12 patients with hyperthyroid Graves' disease and 12 controls. 
Pupil size, pupillary unrest, and The mean pupil size of the patients was 
not different from that of the controls. Pupillary unrest and 
Accommodation in the patients was lower than that of the controls.; 
pupillary unrest and accommodation had improved in all five patients. 
These results indicate that intraocular muscles are sympathetically 
overactive in hyperthyroid patients  . 
                Cavallo A 71, in his research, discovered unusual cardiac manifestations in 
few of hyperthyroid patients like  transient apical systolic murmur , persistent 
cardiomegaly, and the remaining had persistent apical systolic murmurs and 
cardiomegaly, mitral regurgitation and congestive heart failure.  Persistent  and 
severe cardiac morbidity  occurred only in  long standing cases  ,because of the 
poor compliance with  antithyroid  treatment. 
 
               Thomas Seepal72  assessed the metabolic effects of untreated 
hyperthyroids     and  untreated hypothyroids by using Bioelectrical whole 
body resistance (R) and reactance (Xc) for calculating  the lean body 
mass, body cell mass (BCM),    extracellular mass (ECM) and  body fat . 
ECM/BCM ratio was elevated in all    hyperthyroid subjects   due to a loss 
of muscle  mass and  due to an increase   in extracellular fluids but in 
hypothyroidism there is decrease in ECM/BCM .Body composition 
variation could not be  evaluated from the thyroid dysfunction . and he 
showed that BIA  detects  small metabolic manifestations in thyroid 
dysfunction. 105.  
           Loss of weight and increase in weight was observed in thyrotoxic 
patients . In these patients, serum ghrelin levels measured in before and 
during treatment .It was found that  fasting serum ghrelin concentration 
was significantly reduced in the women with hyperthyroidism than in 
the normal women  but it increases after antithyroid drug treatment.  
Also  the hyperthroid individuals  had less body mass and reduced fat 
tissue than the euthyroid women. Following treatment, the body mass 
and weight can be increased significantly. 
                 Lozano HF73 , studied a case  of Graves disease with  congestive 
cardiac failure ,   tricuspid regurgitation with elevated pulmonary venous 
pressure.  All these complications  slowly disappeared as soon as the treatment is 
initialised.  Release of increased pulmonary vasodilators, high output failure and 
endothelial injury induced  are all well known etiology for the emergence of 
autoimmune activity and pulmonary hypertension.  Thus any unexplained cardiac 
failure and elevated pulmonary vascular resistance could be due to 
hyperthyroidism and all the complications are treatable entities. 
 
 
 
 
 
 
  
 IV. MATERIALS AND METHODOLOGY 
                This research study was carried out in our physiology laboratory, after 
getting ethical clearance from the institutional human ethics committee and 
informed consent from the subjects, in both hyperthyroid and control groups. 
The period of study was nine months. 
INCLUSION CRITERIA: 
• Age between 30-50 yrs. 
• Body Mass Index- Between 18.5 to 25. 
• Both males & females   who are  Physically active. 
• Newly diagnosed 30 hyperthyroid patients  with TSH less  than   0.27 micro  
IU/ml 
•   30   normal  volunteers with TSH normal range . 
 
 
EXCLUSION CRITERIA: 
• Hypertensives. 
• Diabetics. 
• Patients on  regular or irregular anti thyroid treatment. 
• The subjects who were  on drugs affecting Autonomic Nervous System like 
anticholinergics, digoxin, minoxidil, theophylline, sympathomimetics, 
phenobarbitone. 
• Females who  were psychiatric patients.   
•  Those who were having BMI more than 25 and less than 18.5 
STUDY POPULATION 
• Newly diagnosed hyperthyroid patients (before starting treatment) 
attending Medical Out Patient department  and normal volunteers.    
•  After getting clearance from Institutional Human Ethics Committee 
(IHEC)  and Department of Clinical Research and Bioethics ( DCRB) 
the subjects who fulfilled the  criteria for study were taken for ECG 
recording and  HRV analysis. 
• Thyroid Function Test  reports, Age in years, Height  in cms, Weight in 
kilograms of  both Hyperthyroid and normal volunteers were collected. 
• A detailed history taking and a complete physical examination was done 
and  a complete record was obtained for future verification. 
 
 ANTHROPOMETRY 
 
Body Mass Index 
           All the subjects were measured for height and weight. From this BMI was 
obtained by dividing weight in kilogram by square  of the height in meters.i.e,  
 
BMI=       weight in kilogram 
            height in meter square 
 
BMI of 18.5 to 24.9 kg/m2  were graded as normal, 25 to 29.9 kg/m2  were graded 
as overweight and more than 30 as obese. Only the participants with normal BMI 
were included in the study 
 
 
BASAL METABOLIC RATE 
          It is defined as the rate of  calorie consumption in the post absorptive state ,in 
the absence of any muscular activity, at a comfortable environmental temperature and 
with the patient resting comfortably.          
             The thyroid hormone is one of the determinant of  energy expenditure ,basal 
metabolic rate  and thermogenesis  . Many studies have showed the effects of thyroid 
hormone on cell metabolism ,involved with energy expenditure. But  I t is not  clear 
whether 3,3'-triiodothyronine dependent  metabolism are most relevant for the 
evaluation  of BMR  . 
   BMR is affected by  various factors like gender,  age, degree of work , thyroid 
hormones,  body temperature,  nutritional  state,  pregnancy,  caffeine and tobacco 
use, growth and development. 
BMR can be responsible for burning up to 70% of the total calories expended. 
 
 
Metric BMR Formula  
 
Women:  BMR = 655+(9.6 x weight in kilos)+ (1.8 x height in cm)-(4.7xage in 
in years)  
  Men: BMR = 66 + ( 13.7 x weight in kilos)+(5 x height in cm) - (6.8 x 
age in years)  
 
THYROID FUNCTION TESTS:  
              In the recent days highly precise thyroid function tests are there to establish 
a diagnosis of hyperthyroidism. The thyroid gland synthesise  levothyroxine (T4)  and 
triiodothyronine  (T3) which is based on the negative feed back loop.  The thyroid 
hormone dysfunction can be studied by TSH assay which is highly sensitive .           
Immunoassay  which we used  for in vitro quantitative determination of T3, 
FT4,TSH, FT3 is ECLIA ( ELECTRO CHEMI LUMINESCENCE IMMUNO 
ASSAY) . This method has been validated for determination of plasma thyroid 
harmones in human samples and commonly are used in medical diagnostic 
Laboratories.  
                   T3  and FT3 assay employs a competitive test principle  with polyclonal  
antibodies. Direct measurement of  FT4 , FT3 via equilibrium  dialysis or 
ultrafilteration is mainly used as a reference method for standardizing the 
immunological procedures used for routine diagnostic purposes. 
                       Free T4  is measured together with TSH , when thyroid function 
disorders are suspected . TSH is a glycoprotein and consists of two subunits, the 
alpha and the beta subunit. 
• The α (alpha) subunit is nearly identical to that of human chorionic 
gonadotropin (HCG), luteinizing hormone (LH), and follicle-stimulating 
hormone (FSH)74 . The α subunit is responsible for stimulation of adenyl 
cyclase and generation of Cyclic AMP. 
• The β (beta) subunit determines its biological  receptor specificity and it is 
unique to TSH. 
           TSH assay is a screening test  and confirm thyroid disorders and to  follow the 
treatment response.  
 
 
Reference range: 
     TSH   -  0.27 to 4.2 micro IU/ml 
FT4   -  0.932  to 1.71 ng/dl 
FT3  -   2 to 4.4 pg/ml 
T3    -  0.846 to 2.02 ng/ml 
 Cases and controls were selected based on this test .  
Subjects whose TSH values  less than 0.27 are taken as cases. 
The volunteers whose  thyroid function tests in the normal range are taken as 
controls. 
 HRV analysis  is done before starting antithyroid treatment in the cases. 
 
 ECG RECORDING AND HRV ANALYSIS 
                  HRV is a non invasive procedure. Recording  electrocardiogram  for 10 
minutes in a computerized physiograph  (NEVIQURE-Digital ECG recorder) in Lead 
II and analysis by using Finland software. 
  
ECG Recording 
                Informed consent was taken from all the subjects before  taking ECG.   
In the research laboratory, the subjects were asked to take rest( i.e, lying quietly in 
the supine position on the couch, awake and not making any movements) for 5 
minutes before the procedure, so as to alleviate unnecessary anxiety and they were 
also made aware about the ECG procedure. 
               ECG was recorded using the computerized physiograph Inco digital ECG 
recorder in  lead II  for a period for 10 minutes  by placing disposable adhesion 
electrodes on the pattern of lead II configuration . 
                Positive electrode was connected to left arm, negative electrode to    right  
arm, reference electrode on left foot and ground electrode on right foot. Baseline 
electro cardiogram were taken from the study population and the subjects with  
abnormal baseline  ECG were excluded. 
                 RR intervals were obtained after clearance of noise and baseline 
fluctuations by digital filters. Those who had ectopic beats were excluded from the 
study. Resting heart rate  is also recorded. The datas were filtered using a digital 
notch filters with a sampling rate of 1000 samples/sec. 
            The inbuilt software selected  the RR peaks and these  RR intervals which 
were obtained as time points were then fed in to a Microsoft excel sheet and RR 
intervals were copied to a notepad file. 
        HRV analysis was done by feeding this RR intervals notepad file.  
                The resting  autonomic activity was assessed by measuring the 10 minute 
heart rate variability and HRV  indices determined are  
                
The Time domain parameters 
 calculated are : 
• Mean RR(NN) 
This is the average of all  NN intervals. At a given physiological state it varies 
inversely with mean heart rate, this also indicates sympatho vagal balance . 
 
• SDNN 
     It is the standard deviation of all NN intervals. 
          It is a measure of total variability. When considered for a short time period, 
        it   reflects HRV in low  and high frequency ranges. 
 
 
• NN50 
It is the number of pairs of adjacent NN intervals differing  more than 50 ms.  
• PNN50  
It is the proportions of NN50 divided by total number of NNs. This is also an 
estimate of high frequency variation in heart rate. 
• RMSSD 
 The square root of the mean of the sum of the squares of  differences  between  
adjacent NN intervals .This is an estimate of high frequency variations in heart 
rate and hence a measure of vagal modulation.  
 Frequency-domain measures: 
           It  shows the HRV at few frequency ranges CORELATING WITH CERTAIN 
physiological processes. All the abnormal beat-beat variations and artifacts were 
analysed and removed.  Tachogram of RR intervals must be sequentially taken to 
make it regularly sampled signal  
          A  routine spectral analysis is applied to our modified recording and all the 
time and frequency domain parameters are analysed on 10-minutes time interval.  
Frequency domain parameters  calculated are: 
• Low frequency power(LF) –It is taken in the range from 0.04 to 0.15 Hz 
.This power  depicts both the divisions of autonomic nervous system . 
• High frequency power- It is taken  in the range from 0.15 to 0.4 Hz. This 
power depicts vagal tone. 
 
• LF norm (nu) - Low frequency power in normalized units.                             
LF/(Total power – VLF) X100 
 
• HF norm (nu) – high frequency power in normalized units.              
HF/(Total power – VLF)X100 
  
• LF/HF power ratio-  It  is used to  depict the sympathovagal imbalance 
.increase in this ratio usually depicts vagal inactivity and sympathetic 
dominance .   
             HRV analysis was done by feeding this Harmonic components of  RR interval 
notepad file to HRV analysis software version 1.1 from Biomedical Signal Analysis 
group, Department of Applied Physics , University of Kuopio, Finland 
              Power spectral analysis was done by fast fourier transformation, discovered  
by  Jean Baptiste Joseph  Fourier. 
Statistical analysis  
       The statistical analysis was done using SPSS software  ( statistical package for 
the social science version- 19 ) By independent Students t’ test, Analysis was done 
between the study group and control group. Both HRV and Thyroid harmone levels 
were compared, which gave the exact relationship between HRV and increased T3, 
T4 and decreased  TSH  levels. 
Values are expressed as Mean +  SD. 
P <0.05 was considered to be statistically significant. 
POWER SPECTRUM OF HRV 
PC display of the HRV analysis software version 1.1 
          The LF/HF ratio was expressed as the ratio of the normalized areas, calculating 
the ratio of the percentage power contained in the LF band to that in the HF band. 
Mean heart rate, LF/HF power ratio , individual  LF  and HF area power , and 
normalized area were individually measured in all subjects for all experimental 
conditions. 
 
 
 
 
v.  RESULTS 
60 patients were subjected t0 ECG recording.  30 patients were newly diagnosed 
hyperthyroid patients before starting treatment and 30 patients were euthyroid. 10 
minute Elecro cardiogram  was taken for all the 60 patients and HRV analysis was 
done. 
            The HRV parameters (Time domain measures and the frequency domain 
measures) were compared between the cases and controls. 
            Both HRV and thyroid hormone levels were compared, which gave the exact 
relationship between HRV and increased T3, T4 and decreased Thyroid Stimulating 
Harmone (TSH) levels. 
 
 
 
ANALYSIS BETWEEN   CASE AND CONTROLS. 
1. Baseline characteristics of the Hyperthyroids and   normal 
volunteers 
Results are expressed as Mean + SD. 
Age (in yrs) 
 Mean  age of the  Hyperthyroids  was 39.23 ± 6.91 and the Euthyroids was 42.13 ±  
6.78 .There was no significant difference between ages with  p value 0.140. 
  Height (in cms) 
            
 
2. Resting Heart rate and BMR of the Hyperthyroids and  normal 
volunteers 
      
 Resting Heart rate (RHR  per min) 
Height of Hyperthyroids was 160.40  ±  6.52 and Euthyroids was 159.27 ± 7.58. 
There was no significant difference in weight between these groups with p value 
0.551 . 
Weight (kgs) 
Weight of Hyperthyroids was 58.50±6.21 and Euthyroids was 59.03± 7.02. There 
was no significant difference in weight between these groups with p value 0.781. 
  BMI (kg/m2) 
BMI of the Hyperthyroids was 22.70±1.64 and the euthyroids was 22.86±1.28. 
There was no significant difference between BMI with p value 0.671. 
 
 
 
 
                   RHR of the hyperthyroids was   97.67 ±17.71 and euthyroids was  
       74.47 ±5.34 and the p value <0.001 ( extremely significant) 
     
 Basal Metabolic Rate ( BMR) 
BMR of hyperthyroids was 1348± 122.88 and euthyroids was 1332 ± 117.48 
and the p value 0.641. 
 
 
 
3.  Comparison of frequency domain measures of the Hyperthyroids         
and   normal volunteers 
 Low power frequency in normalized units(  LF n.u) 
   LF of the Hyperthyroids was 78.99. ± 10.38 and Euthyroids was 50.99± 12.23 
and p value<0.0001 (extremely significant). 
High power frequency in normalized units (HF n.u) 
   HF of the Hyperthyroids was 21.47±9.96 and Euthyroids was 48.98± 12.24 and  
p value<0.0001 (extremely significant) 
LF/HF ratio 
   LF/HF of the Hyperthyroids was 4.81±2.81and Euthyroids was 1.17± 0.57 and  
p value<0.0001 (extremely significant). 
Low power frequency ( LF ) power % 
LF of the Hyperthyroids was 31.333 ± 12.68 and euthyroids was 26.213± 9.71 
and p value of 0.070 (significant). 
 
High power frequency (HF) power % 
      HF of the Hyperthyroids was 8.49±7.66 and euthyroids was 28.39± 13.99 and p 
value<0.0001 (extremely significant). 
Very Low power frequency (LF) power % 
    LF of the Hyperthyroids was 59.11. ± 21.098 and the Euthyroids was 46.35± 
18.35 and p value of 0.008 (significant). 
 
 
  
 
 
 
 
4. Comparison of time domain measures of the of the Hyperthyroids  
and   normal volunteers 
 
Mean RR(s) 
         Mean RR of the Hyperthyroids was 0.62±0.11 and the Euthyroids was 
0.77±0.062. There was significant difference between the Mean RR of both the 
groups with p value<0.0001 (extremely significant). 
 
RMSSD 
         RMSSD of the Hyperthyroids was 14.19± 7.69 and Euthyroids was 38.66 ± 
7.66 and p value of <0.0001 (extremely significant). 
NN 50(count) 
    NN 50 of the Hyperthyroids was 8.67± 8.07and Euthyroids was 79.67 ±17.34 
and p value <0.0001 (extremely significant). 
pNN50  (%) 
   pNN50  of the Hyperthyroids was 4.30± 4.02 and Euthyroids was  21.46 ±12.53 
and p value < 0.0001(extremely significant) 
 
SDNN( ms). 
 SDNN of the Hyperthyroids was 24.297 ± 12.359 and Euthyroids was  
39.67±8.625 and  p value < 0.0001(extremely significant). 
 
 
 
 
  
 
5. Comparison of TFT (ELECSYS IMMUNOASSAY) of   Hyperthyroid and      
Euthyroid groups. 
SERUM TSH (in µ IU/ml) 
   Mean TSH of the Hyperthyroids was 0.017 ±0.019 and Euthyroids was2.0 9±0.062 
with p value<0.0001 (extremely significant). 
T3 (in ng/ml) 
      T 3  of the Hyperthyroids was 2.94± 1.71 and  Euthyroids was 1.20± 0.175 and 
p value <0. 001 (significant). 
 
FT4 (in ng/ml) 
        FT4 of the Hyperthyroids was 2.91± 1.97 and  Euthyroids was 1.11 ± 0.18 and 
p value <0.0001 (extremely significant). 
FT3 (in Pg/ml) 
      FT3 of the Hyperthyroids was 7.33± 6.75 and Euthyroids was 2.09±0.85 and p 
value <0.001 (significant) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 1. Comparison of Baseline characteristics of Hyperthyroid and Euthyroid 
groups 
Table-1 
Parameter Group Mean±SD P  Value 
Age(yrs) Cases 39.23± 6.91 0.140 (NS) 
Controls 42.13±  6.78 
Height 
 
Cases 160.40± 6.52 0.551 (NS) 
Controls 159.27± 7.58 
 
Weight 
Cases 58.50 ±  6.22 0.781( NS) 
 Controls 59.03±  7.02 
 
BMI(kg/m2) 
Cases 22.70±  1.64 0.671 (NS)
 
Controls 22.86 ±  1.29 
 
NS-
    
Not significant 
*
  Significant 
**
 Very significant 
***
 Extremely  significant 
 
2. Comparison of Resting Heart rate and BMR of the Hyperthyroids 
and   Euthyroid groups 
 
Table-2 
 
NS-
    
Not significant   
*
  Significant    
**
 Very significant 
 
Parameter Group Mean±SD P  Value 
RHR Cases 97.67±17.71 <0.005** 
Controls 74.47±  5.34 
BMR Cases 1348± 122.88 0.641 (NS) 
Controls 1332± 117.48 
  
 
 
3.Comparison of Frequency domain measures of Hyperthyroids &Euthyroids 
Table-3 
 
  Parameter 
 
Group 
 
Mean ±SD 
 
P value 
 
LF nu 
Cases 78.996±10.383  
<0.0001*** Controls 50.993±12.226 
 
HF nu 
Cases 21.466±9.965  
<0.0001*** Controls 48.983±12.240 
 
LF/HF ratio 
Cases 4.8150±2.811  
<0.0001*** Controls 1.174±0.5721 
  
 
LF power 
 
Cases 
 
31.33±12.683 
 
 
<0.0001*** 
 
Controls 
 
26.21±9.710 
  
HF power 
 
Cases 
 
8.496±7.669 
 
 
  
 
NS
    
Not significant     
*
  Significant   
**
 Very significant      
***
 Extremely  significant 
4. Comparison of time domain measures of Hyperthyroids and 
Euthyroids 
 
Controls 
 
28.396±13.985 
<0.0001*** 
 
 
VLF power 
 
 
Cases 
 
59.114±21.098 
 
 
<0.0001*** 
 
Controls 
 
46.350±18.356 Parameter Group Mean ±SD P value 
    Table-4 
NS
    
Not significant     
*
  Significant   
**
 Very significant      
***
 Extremely  significant 
 
 
 
 
Mean RR(s) 
Cases 0.621±0.106 <0.0001
***
 
 
Controls 0.769±0.062 
 
SDNN(ms) 
Cases 24.297±12.36 <0.0001
*** 
Controls 39.675±8.63 
 
RMSSD 
Cases 14.196±7.69 <0.0001
***
 
 
Controls 38.656±7.66 
 
NN50(count) 
Cases 8.67±8.07 <0.0001
*** 
Controls 79.67±17.35 
 
pNN50(%) 
Cases 4.30±4.0 <0.0001
*** 
Controls 21.46±12.53 
5. Comparison of TFT (ELECSYS IMMUNOASSAY) of 
Hyperthyroid and Euthyroid groups. 
Table-5. 
 
NS
 -   
Not significant
            *
    Significant     
**
  Very significant         
    
***
 Extremely  significant
 
serum Normal range Group Mean ±SD P value 
 
TSH 
(µ IU/ml) 
 
0.27-4.2 
Cases 0.017±0.019  
0.0001*** Controls 2.091±0.853 
 
 
 
T3 
(ng/ml) 
 
 
 
0.846-2.02 
 
 
 
Cases 
 
 
2.938±1.71 
 
 
 
   
0.001**    
 
Controls 
 
1.202±0.175 
 
 
FT4 
(ng/dl) 
 
 
 
0.932-1.71 
 
Cases 
 
 
2.908±1.97 
 
 
 
0.0001*** 
 
Controls 
 
1.108±0.177 
 
FT3 
(pg/ml) 
 
 
 
2-4.4 
 
 
 
Cases 
 
 
7.33±6.747 
 
 
0.001**    
 
Controls 
 
2.091±0.853 
  
VI. DISCUSSION 
               Thyroid hormones modulates  the development, growth  and metabolism  
of each and every system in our body  .Hyperthyroidism is due to hyperactive 
thyroid gland  and increased production of thyroid hormones T3 , T4  and 
decreased serum TSH.  
            
        Hyperthyroidism frequently presents with tachycardia, palpitations and 
widened pulse pressure. Cardiac contractility and cardiac output is immensely 
elevated in hyperthyroids due to the additive effect of elevated ejection fraction, 
resting heart rate, and blood volume with a decrease in diastolic function.                                     
Sympathetic nervous system activation and  thyrotoxicosis manifestations are 
mostly similar, especially in the ionotrophic effects 
  
              The thyroid hormone receptor isoforms alpha and beta are bound to the 
oligomer within the retinoid X receptor. α- MHC predominates in the atria of 
adults 75. 
             Recent studies in heart showed that thyroid hormones especially  cause 
enhanced gene  transcription of the  calcium ATPase in sarcoplasmic reticulum and 
increase the pacemaker activity in cardiac  cell            
            
                Thyroid hormone  has its effect on  duration of cardiac pacemaker 
potential and repolarization currents. It alters both non genomic and genomic 
actions and the net effect is to alter the heart function towards increased 
contractility 76. 
             It is possible that there exists an interaction between the adrenergic 
hormones and the thyroid hormoneS, which may also contribute to the cardiac 
actions of thyroid hormone77. 
              A study done by Williams showed  that thyroid hormones increase 
sensitivity to β-adrenergic agonists by increasing the β-adrenoceptor density and 
Gs/Gi protein ratio with an  excess activation of  the adenylate cyclase 78. 
                    HRV is the good marker for identifying the cardiovascular risk and 
severity in hyperthyroids. HRV denotes the individuals autonomic tone and   
Frequency domain measures are considered to be best semiquantitive method for 
parasympathetic and sympathetic activity. 
                Increase in  sympathetic tone in cardiac pacemakers induces tachycardia 
and reduce  HRV, whereas increased parasympathetic activity causes bradycardia 
and increases beat  to beat differences. 
                 Higher HRV is always desirable and Lower Heart Rate variability is an 
established marker of cardiovascular deaths and complications .  Abnormal 
variability also predicts the cardiovascular etiology for mortality, coronary 
atherosclerotic development and  cardiac arrhythmias.  
                   In this study population, cases showed decreased HRV parameters. Of 
the HRV parameters, frequency domain measures HF power, HF nu was less 
among patients than controls. This clearly depicts that parasympathetic activity is 
less among hyperthyroid patients. 
             Thyroxine  hormone increase the body temperature and produce 
vasodilatation.This increase the cutaneous circulation. But decrease in the 
peripheral resistance with decrease in diastolic blood pressure. 
             There is decrease in the circulation time, due to increase in the blood flow 
velocity. Inspite of increased cardiac output, there is less tissue perfusion ,thus 
causing dyspnea in high output cardiac failure. 
                 LF nu, and LF power and LF/HF Ratio were high among hyperthyroids 
than controls. This shows that sympathetic activity is high in hyperthyroid patients 
and it is consistent with the study done by chiu HW and chen JL  who  emphasized 
that hyperthyroidism is characterized by a abnormal  increase in  sympathetic and 
decrease in  vagal activity in heart. 
            So the sympathetic to vagal ratio may increase in Hyperthyroids. But few 
young Euthyroid patients (with normal TFT), have  LF/HF ratio more than 1, 
showing little sympathetic dominance, which can be due to stress. However it is 
negligent when compared to hyperthyroid patients with enormous hike in LF/HF 
ratio.  
                 In our study, basal metabolic rate is elevated in few hyperthyroid 
patients than the controls. By Calculating the BMR it is clear that BMR elevation 
is directly proportional to the increase in T3, T4    and LF. (Low frequency domain 
measuring sympathetic activity) .This relationship is well brought out in our study 
than the previous studies. But there are few hyperthyroid  patients, who had normal 
BMR. This depicts all hyperthyroid patients need  not have elevated BMR. 
           Of the time variables, mean RR interval, p NN 50 and NN50 were less 
among the patients than controls, relating to the parasympathetic withdrawal. 
            Similarly SDNN and RMSSD were significantly lower in untreated 
hyperthyroids than euthyroids.  This shows that high frequency variations in heart 
rate are less and vagal modulation of the autonomic nervous system   is decreased. 
             A certain number of cases showed   NN50 and pNN50 equals 0. It 
emphasizes that adjacent NN intervals differing by more than 50ms is zero .So the 
high frequency variations in heart rate in these patients were zero. Thus the vagal 
activity is least. These patients are high risk patients for cardiovascular 
complication   like atrial fibrillation and arrhythmias. Our study is of great 
relevance in this aspect. 
               Supraventricular arrhythmias , atrial fibrillation , cardiac failure are the 
known  cardiovascular complications of thyrotoxicosis  and the same was proved 
to be the primary cause of death.  
             There is an association between thyroid  gland function, heart muscle 
mass, and ventricular hypertrophy. Hyperthyroidism is an independent risk      
factor for LVH.  
            In the geriatric age group, the TSH levels are low, and  the 
preponderance for atrial fibrillation  and right heart failure  is twice than that of 
middle aged people.  
            Left Ventricular Hypertrophy  has emerged as a important marker of 
progressing  atheroscleroticprocesseswhich can be appreciated  by ECG, ECHO or 
X-ray and  Cardiovascular complications proportionately increase with increasing  
left ventricular muscle mass .  
              TSH values were significantly reduced in hyperthyroids.  TSH has a linear 
relationship with parasympathetic activity.T3, T4 were immensely elevated, which 
is directly proportional with sympathetic activity and the degree of vagal 
withdrawal. This relationship is well brought out in our study than any other 
previous studies. 
              Our study gives a solid and strong evidence of increased cardiac 
autonomic activity –showcasing the sympathetic dominance as the culprit for all 
cardiac morbidity and mortality. 
           With the help of our HRV analysis in hyperthyroids, patients who are at risk 
for cardiac complications are found out using the time and frequency domains and 
early intervention can be done to prevent mortality rates. 
            β-adrenergic blockers (β1-selective or nonselective agents )could be 
suggested for high risk cases as an initiative measure.  Tachyarrythmias can be 
converted to sinus rhythm patterns  and normal conducting patterns can be 
obtained by  radioactive iodine, antithyroid drugs and thyroidectomy. It all needs a 
brief period of time to bring it to normal cardiovascular status. 
LIMITATIONS OF THE STUDY 
Few limitations observed are, 
1. Sample size of the study can be more. 
2.  It is difficult to get patients before starting  anti thyroid treatment. 
 
VII. Conclusion 
 
            To our knowledge , this is the first study to investigate the autonomic 
innervations of the heart  in thyrotoxicosis subjects  using HRV analysis and 
comparison of BMR between the case and control groups. 
             The results of our study show that there is reduced parasympathetic 
component and elevated  sympathetic component  in hyperthyroid patients. The 
cause is found to be the reduced levels of TSH levels as well as the increased 
thyroid hormones. 
              In the view of present study results, disturbances of sympathetic branch of 
Autonomic Nervous System  can be observed in patients with thyrotoxicosis. 
               A predominance of sympathetic tone has cardio acceleratory effect and 
reduced beat-to-beat variations and therefore causes positive ionotrophic effects. 
             Reduced Heart Rate variability is most commonly linked with a risk of 
arrhythmic death and it is the independent predictor of cardiac mortality and 
morbidity, but recent data suggests that any abnormal variability also predicts 
circulatory dysfunction, progression of coronary atherosclerosis and death due to 
arrythmias. 
              The beta adrenergic blocking drugs reduce both cardiovascular and central 
nervous symptoms. It helps to reduce the anxiety while preparing patients for 
surgery. 
              Beta-adrenergic blockers slow the resting heart rate from 97 to 80 
beats/min and bring the rate of diastolic deceleration to normal . 
             Beta blockers are usually prescribed to reduce the symptoms of 
thyrotoxicosis  such as tachycardia ,  palpitations, tremors, anxiety. Anti-thyroid 
treatment  given  to  decrease the synthesis of thyroid hormones ,  particularly, in 
the case of Graves' disease . 
              We  conclude that decreased vagal modulation on heart rate may occur in 
hyperthyroidism, which may be restored following adequate treatment of the 
disease  by blocking beta receptors and there by inhibiting the adenylyl cyclase- 
cyclic AMP pathway. 
          This provides an attractive future option for management of arrhythmias and 
other cardiovascular complications due to thyrotoxicosis.  
          From our study it is obvious that cardiovascular risk in thyrotoxicosis 
patients can be evaluated by our HRV analysis before any appreciable change 
occurred in heart rate itself. Prevention is better than cure. So even before the 
appearance of cardiac complications, they can be assessed and halted. 
        Many randomised control trials can be done to bring out the unexplored 
effects of autonomic dysfunction on cardiovascular system.  Thus cardiac 
morbidity can be assessed and treated earlier and mortality can be prevented using 
our HRV analysis. 
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